Le Fonti Award - Another award for Theras

08
June
2020

Le Fonti Award - Another award for Theras

Le Fonti Award - Another award for Theras

“Excellence of the Year in Innovation and Leadership of Medical Devices”.

We are delighted of this important recognition.

On the occasion of the “Le Fonti Awards” 2020, a consolidated event that has been repeated for the past 10 years, the “Le Fonti” award was given to us.

Cristiano Ferarri, our Managing Director, who virtually withdrew the Award, wanted to express his reflection:

“We are continuing with great satisfaction to confirm the success of a company that has been showing great results since 2011.

There are many components that are contributing to the success of a company like ours, starting from the company system, passing from products to personnel.

The company was founded for the distribution of high-tech products in the healthcare sector, but it was physiological to integrate these devices with others developed internally.

Some are already on the market while others are coming in the next few years, such as the revolutionary Nanopain, a device for the treatment of pain that uses nanotechnologies, developed in partnership with the CNR."

The motivation for the award, expressed at the meeting, is "To be a leader in the research and marketing of advanced technologies for the treatment and monitoring of diabetes and for the management of chronic pain.

For the constant commitment to ensure excellence in terms of quality and to support innovation and technological progress, investing in research and development ".

For more information, you can visit the article here.


Related news

Theras, champion of growth

Theras, champion of growth

Read more

Theras Group earns major recognition from Great Place to Work

In its first year of participation, Theras achieved the Great Place of Work certification.

Read more

Winners of the 'Dexcom International Marketing Award' (DIMA) for 2020

Putting the patient at the centre and supporting healthcare professionals always pays off.

Read more